Strong synergy is provided by interferon (IFN)γ released from e.g., innate lymphocytes such as NK, NKT, or Gamma Delta (γδ) T Cells driving release of inflammatory cytokines including interleukin (IL)-12p70 (4), which control IFNγ-dependent adaptive immunity in conditions of viral infection and cancer (5). The gene discussed is IFNG; the disease is cancer.